Lung cancer is the leading cause of cancer deaths worldwide, and this makes it an attractive
disease to review and possibly improve therapeutic treatment options. Surgery, radiation …

Thyroid cancer is one of the few malignancies that are increasing in incidence. Recent
advances have improved our understanding of its pathogenesis; these include the …

Anaplastic thyroid cancer (ATC) is an uncommon malignancy of the thyroid. Only 1‐2% of
thyroid cancers are anaplastic, but the disease contributes to 14–50% of the mortality with a …

Anaplastic thyroid cancer (ATC) is a rare malignancy. While external beam radiation therapy
has improved locoregional control, the median survival of∼ 4 months has not changed in …

Anaplastic thyroid cancer (ATC) is undoubtedly the thyroid cancer histotype with the poorest
prognosis. The conventional treatment includes surgery, radiotherapy, and conventional …

Treatment of metastatic differentiated thyroid cancer (DTC) includes the use of radioiodine
and suppressive thyroid hormone treatment. A third of patients with distant metastases (who …

Objective: To determine the efficacy of gefitinib in patients with advanced thyroid cancer.
Design: In this open-label phase II trial, 27 patients with radioiodine-refractory, locally …

The incidence of thyroid cancer (TC) has increased rapidly worldwide in recent years.
Exposure to endocrine disruptors can affect thyroid hormones and is probably carcinogenic …

Therapeutic options for patients with metastatic medullary thyroid carcinoma (MTC) are
limited due to lack of effective treatments. Thus, there is a need to thoroughly characterize …

Anaplastic thyroid cancer (ATC) is among the most lethal types of cancers, characterized as
a fast‐growing and highly invasive thyroid tumor that is unresponsive to surgery and …